Drugs Approved for Soft Tissue Sarcoma

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in soft tissue sarcoma that are not listed here.

Drugs Approved for Soft Tissue Sarcoma

Afamitresgene Autoleucel
Atezolizumab
Atezolizumab and Hyaluronidase-tqjs
Cosmegen (Dactinomycin)
Dactinomycin
Doxorubicin Hydrochloride
Eribulin Mesylate
Fyarro (Sirolimus Protein-Bound Particles)
Gleevec (Imatinib Mesylate)
Halaven (Eribulin Mesylate)
Imatinib Mesylate
Pazopanib Hydrochloride
Sirolimus Protein-Bound Particles
Tazemetostat Hydrobromide
Tazverik (Tazemetostat Hydrobromide)
Tecelra (Afamitresgene Autoleucel)
Tecentriq (Atezolizumab)
Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
Trabectedin
Votrient (Pazopanib Hydrochloride)
Yondelis (Trabectedin)

Drugs Approved for Soft Tissue Sarcoma

Drugs Approved for Soft Tissue Sarcoma

Drug Combinations Used in Soft Tissue Sarcoma